The use of 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid (BODIPY-FL) labeled casein in autoquenching assays of proteolytic activity has been recently described, and we have adapted this assay to measurement of calpain activity. BODIPY-FL coupled to casein at a ratio of 8 mol of BODIPY-FL/mol of casein or higher produces a BODIPY-FL-casein substrate that can be used in an autoquenching assay of calpain proteolytic activity. This assay has a number of advantages for measuring calpain activity. (1) The procedure does not require precipitation and removal of undegraded protein, so it is much faster than other procedures that require a precipitation step, and it can be used directly in kinetic assays of proteolytic activity. (2) The BODIPY-FL-casein assay is easily adapted to a microtiter plate format, so it can be used to screen large numbers of samples. (3) Casein is an inexpensive and readily available protein substrate that more closely mimics the natural substrates of endoproteinases, such as the calpains, than synthetic peptide substrates do. Casein has K m values for -and m-calpain that are similar to those of other substrates such as fodrin or MAP2 that may be "natural" substrates for the calpains, and there is no reason to believe that calpain hydrolysis of casein is inherently different from hydrolysis of fodrin or MAP2, which are much less accessible as substrates for protease assays. (4) The BODIPY-FL-casein assay is capable of detecting 10 ng (ϳ5 nM) of calpain and is nearly as sensitive as the most sensitive calpain assay reported thus far. (5) The BODIPY-FL-casein assay is as reproducible as the FITC-casein assay, whose reproducibility is comparable to or better than the reproducibility of other methods used to assay calpain activity. The BODIPY-FL-casein assay is a general assay for proteolytic activity and can be used with any protease that cleaves casein.
Assays of proteolytic activity have traditionally faced one of two difficulties. (1) If a protein substrate is used in an effort to mimic the natural substrates of the protease, the undigested protein remaining after the incubation must first be precipitated with some protein-precipitating agent, the precipitated protein removed by centrifugation, and the acid-soluble peptides/ amino acids then measured by using absorbance at 278 nm (1, 2) , by using fluorescence if the substrate has been labeled with a fluorescent compound such as fluorescein isothiocyanate (3, 4) , or by determining the free amino groups produced during proteolysis by using fluorescamine (5, 6) or similar reagents such as ninhydrin (7) or 2,4,6-trinitrobenzenesulfonic acid (8) . Radiolabeled substrates such as 14 C-methylated or 3 Hlabeled protein (9 -11) can be used and provide greater sensitivity than absorbance at 278 nm or ninhydrinbased assays. Radiolabeling, however, can be tedious, and radioactive waste is regarded as environmentally hazardous, and its disposal is becoming increasingly expensive. Moreover, even after radiolabeling, the undigested protein must still be precipitated, and the precipitated protein removed by centrifugation. Finally, in addition to being time-consuming, all assays involving precipitation of undegraded protein are subject to the variations caused by differences in the ability of different reagents and different concentrations of these reagents to precipitate polypeptides (12) .
(2) Many of the difficulties associated with precipitation of undigested protein are circumvented by the use of a soluble peptide that has been tagged with a fluorophore or other compound that fluoresces or absorbs light after it has been released from the peptide by the proteolytic enzyme. The undigested peptide does not need to be precipitated, and the time course of the proteolytic digestion can be easily monitored in a fluorometer or spectrophotometer (13) . Although assays of proteolytic activity using labeled peptide substrates are much more convenient and rapid than assays using proteins as substrates, peptides in many instances do not mimic natural substrates, especially for endoproteinases, and therefore may not provide an accurate estimate of the proteases' true activity. This is true for the two calpains, -and m-calpain, 2 which have apparent K m values in the 10 -53 M (9, 14 -16) to 40 -60 nM (17, 18) range when assayed with protein substrates but have K m values in the millimolar range when assayed with a variety of synthetic peptide substrates (13, 19, 20) . Hence, substrate concentrations in excess of 2-5 mM are required to assay -or m-calpain at more than half-maximal activity if such synthetic substrates are used, and many synthetic peptides are poorly soluble at such high concentrations. Reversible inhibitors such as leupeptin and antipain have K i values of 0.32 and 0.43 M (leupeptin) and 1.41 and 1.45 M (antipain) for -calpain and m-calpain, respectively (20) , so assays of calpain activity using synthetic peptide substrates are much more susceptible to unsuspected inhibition than when using protein substrates.
Hence, an ideal assay for proteolytic activity, especially for endoproteinases such as the calpains, would use a protein substrate but would not require precipitation of the undigested protein to measure extent of proteolysis. Raser et al. (21) used a casein zymography assay to measure calpain activity, but this assay is very time-consuming and is not useful for kinetic studies or a large number of assays. Another assay used the ability of Coomassie brilliant blue G-250 to bind preferentially to proteins rather than to their proteolytic fragments to measure protease activity and thereby eliminated the need to remove undigested protein before measuring the degree of proteolysis (16) . This assay, however, could detect only 5-10 g of calpain and therefore lacks the sensitivity of most other assays.
It was shown several years ago that multiple labeling of a protein with a fluorescent compound can lead to "autoquenching" by the adjacent fluorophores and thus to an increase in fluorescence when these fluorophores are released by proteolysis (22, 23) . Consequently, it is possible to assay for proteolytic activity by using a suitably labeled protein substrate and measuring the increase in fluorescence as fluorophores are released by proteolysis. This approach does not require removal of the undigested protein before the extent of proteolysis can be measured. Fluorescein isothiocyanate-labeled (FITC-labeled) bovine serum albumin, FITC-labeled casein, and FITC-labeled transferrin were used to determine the proteolytic activity of trypsin, chymotrypsin, and elastase with this autoquenching method (23) . The assays were able to detect 50 -100 ng of protease. Tompa et al. (24) labeled the cytoskeletal protein, MAP2, with 5-[(4,6-dichlorotriazin-2-yl)amino]fluorescein (DTAF) and were able to detect 7 ng (1.27 nM) of -calpain activity in an autoquenching assay. Although the DTAF assays are very sensitive, they are inconvenient for large numbers of assays, because they use a spectrofluorometer and quartz cuvette. We attempted to adapt the procedure described by Tompa et al. (24) to a more readily accessible substrate, casein, but casein labeled with DTAF gave very high background fluorescence in microtiter plate assays, and the assay, therefore, lacked sensitivity. We have labeled casein with the fluorophore 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid (BODIPY-FL) and have adapted this autoquenching assay (25) to a microtiter plate format for assay of calpain activity. The calpains have a very restrictive specificity that depends largely on conformation of the substrate (26) . Because the calpains typically cleave only a few peptide bonds in their substrate proteins (27, 28) , it was unclear whether an autoquenching assay can be used successfully to measure calpain activity. The BODIPY-FL casein microtiter plate assay described here is convenient, easily accommodates very large numbers of sample, allows for continuous monitoring of calpain proteolysis, and is sensitive to 10 ng of calpain.
MATERIALS AND METHODS
Materials. BODIPY-FL was purchased from Molecular Probes (Eugene, OR; catalog no. D-2184, a succinimidyl ester derivative), Hammersten casein was obtained from United States Biochemical Corp. (Cleveland, OH), -calpain and m-calpain were purified from bovine skeletal or cardiac muscle, human placenta, or human platelets according to Thompson and Goll (29) , and DMSO was HPLC/spectrograde from Pierce (Rockford, IL). Tris(carboxyethyl)phosphine (TCEP) and GELCODE Blue Stain Reagent were also purchased from Pierce. All other chemicals were analytical reagent grade or purer.
Preparation of BODIPY-FL-labeled casein. Five milligrams of BODIPY-FL is dissolved in 0.5 ml of DMSO, and the dissolved BODIPY-FL is added dropwise with stirring to a casein solution that contains 30 mg of Hammersten casein dissolved in 3.0 ml of 75 mM NaHCO 3 , pH 8.5. Addition of the BODIPY-FL in DMSO results initially in a suspension that dissolves after 1 h of stirring. The suspension/solution is stirred for 3 h at room temperature while keeping it protected from light. After labeling, the BODIPY-FL casein is dialyzed against six changes of 2 L each of deionized water or until the dialysate has no fluorescence. If the protein precipitates during dialysis, a few crystals of (NH 4 ) 2 CO 3 can be added to adjust the pH until the protein dissolves. The (NH 4 ) 2 CO 3 can be removed later by lyophilization. The BODIPY-FL-labeled casein should be protected from light and is stable for at least several months if stored as aliquots frozen at Ϫ20°C or lyophilized (it may be necessary to add ϳ1% DMSO to the solution to dissolve the lyophilized BODIPY-FLcasein). It is stable for several weeks if stored in solution at 4°C. Longer storage times result in increased blank fluorescence values (fluorescence before proteolytic degradation), especially at high levels of BODIPY-FL-casein ( Fig. 1) .
To ensure that the BODIPY-FL-casein is labeled at a level of substitution high enough to nearly completely quench its fluorescence before proteolytic degradation, the degree of substitution can be determined by measuring absorbance of the BODIPY-FL-casein at 502 nm. The molar extinction coefficient for BODIPY-FL at 502 nm is ϳ85,000 M Ϫ1 cm Ϫ1 (Molecular Probes, Handbook of Fluorescent Probes and Research Chemicals; this coefficient will vary from lot to lot and should be matched with the coefficient given with the lot being used). The amount of protein in the BODIPY-FL-labeled casein was measured by using the bicinchoninic acid (30) or Coomassie Plus Protein assay (Pierce). The average molecular mass of the casein isoforms in Hammersten casein was taken as 25,000 Da. We find that the degree of substitution must be at least 8 mol of BODIPY-FL/mol of casein to ensure autoquenching. We typically obtain 9 -11 mol of BODIPY-FL/mol of casein by using the procedure described in the preceding paragraph. The composition of the different casein isoforms in Hammersten casein (31) is approximately 39% ␣S1-casein (15 Lys residues/mol), 10% ␣S2-casein (25 Lys residues/mol), 37% ␤-casein (12 Lys residues/ mol), and 13% ␥-casein (15 Lys residues/mol), so approximately 60 -75% of all Lys residues in Hammersten casein are labeled with this procedure. Labeling at less than 8 mol of BODIPY-FL/mol of casein results in high blank values, indicating insufficient quenching of the BODIPY-FL fluorophores. Other forms of BODIPY such as BODIPY-TR-X (25) can also be used, but we have not tested these fluorophores.
Calpain assay using BODIPY-FL-casein. Black microtiter plates are used to minimize background fluorescence and "cross-talk" among separate wells in a microtiter plate. In a typical assay, 25 l of a calpaincontaining solution is added to a microtiter plate well, and 75 l of dilution buffer [20 mM Tris-HCl, pH 7.5; 1 mM EDTA; 100 mM KCl; 0.1% MCE] is added to bring the total volume to 100 l. The reaction is initiated by adding 100 l of BODIPY-FL-casein (5 g of casein/ml) in 20 mM Tris-HCl, pH 7.5; 1 mM EDTA; 10 mM Ca 2ϩ ; 100 mM KCl; 0.1% MCE to each well. The plate is then covered with foil and is incubated at 25°C for a selected period of time (single-point assay) before being placed in a Tecan Spectrafluor fluorometer and reading the fluorescence at 485-nm excitation and 535-nm emission. For assays requiring incubation above ambient temperature, incubation can be done in the Spectrafluor itself because it is capable of regulating temperature in the range of 25-40°C. The reaction is initiated by adding BODIPY-FL-casein instead of enzyme because a number of wells can be filled simultaneously with a multichannel pipette. Alternatively, the microtiter plate can be placed immediately in the Spectrafluor after the addition of BODIPY-FL-casein, and the time course of casein hydrolysis monitored (the Spectrafluor can record readings every 20 s even if all wells in a 96-well plate are read and in less time if only some of the wells are filled). Earlier studies using quenched fluorescent substrates have noted that the increase in fluorescence begins within seconds once the reaction has been initiated (24, 25, 32, 33) , and it is important to place the microtiter plate in the fluorometer as rapidly as possible after addition of the BODIPY-FL-casein. Every assay includes two blanks, an EDTA blank and a Ca 2ϩ blank. The EDTA blank contains 25 l of 100 mM EDTA, 50 l of dilution buffer, 25 l of calpain-containing sample, and 100 l of BODIPY-FL-casein in each microtiter plate well; and the Ca 2ϩ blank contains 100 l of 20 mM Tris-HCl, pH 7.5; 1 mM ETDA; 100 mM KCl; 0.1% MCE plus 100 l of BODIPY-FL-casein with no calpain. The reaction is stopped by addition of 25 l of 100 mM EDTA. Calpain activity is calculated as follows:
where FU is fluorescence units read from the fluorometer.
Calpastatin assay using BODIPY-FL-casein. These assays also use black microtiter plates. Approximately 500 -750 ng of purified or partly purified calpain in 75 l or less is added to the microtiter plate well and 25 l of a calpastatin-containing sample is then added to the same well. The total volume in the well can be made up to 100 l if needed by adding sample dilution buffer (see preceding section). As with the calpain assay, the reaction is started by adding 100 l of BODIPY-FLcasein (5 g of casein/ml). Each assay again has two blanks, an EDTA blank and a Ca 2ϩ blank. The EDTA blank contains 25 l of 100 mM EDTA in place of a calpastatin-containing sample, and the Ca 2ϩ blank contains all the ingredients except for the calpastatin. The percentage inhibition is calculated as follows:
FU inh ϭ FU sample Ϫ FU EDTA blank and FU uninh ϭ FU Ca blank Ϫ FU EDTA blank , % Inhibition ϭ ͑FU uninh Ϫ FU inh ͒/FU uninh ϫ 100.
If they are washed carefully, the black microtiter plates can be reused to reduce expense.
Other procedures. SDS-PAGE was done according to Laemmli (34) using 8 ϫ 10 cm slab gels that are 0.75 mm thick. The calpains autolyze rapidly at temperatures of 30°C or above and lose their activity within 5-15 min (35) , so all assays were done at 25°C. Results obtained using BODIPY-FL-casein and the microtiter plate procedure were compared with results obtained using the FITC-casein assay (4) that has commonly been used in our laboratory.
RESULTS AND DISCUSSION

Hydrolysis of BODIPY-FL-casein by the calpains.
The response of BODIPY-FL-casein to proteolytic hydrolysis is very rapid; an appreciable increase in fluorescence has occurred already by the time the microtiter plate has been placed in the fluorometer (about 30 s). The "initial burst" of fluorescence (1-5 min in Fig. 2 ) is followed by a slower, linear increase in fluorescence that lasts for 30 min or more depending on the amount of calpain present (Fig. 2) . This initial burst seems to be characteristic of assays involving autoquenched substrates because it occurs when MAP2 is labeled with DTAF (24), when bovine serum albumin is labeled with fluorescein (32), or when glycophorin A is labeled with BODIPY-FL (33) . The initial fluorescence of the BODIPY-FL-casein used in our studies was low; fluorescence readings of 70 -80 were obtained with the instrument settings we typically used. Long storage times (Fig. 1 ) resulted in initial readings of approximately 120 -140 fluorescence units under identical conditions. Therefore, the extensive labeling we achieved (60 -75% of available residues) resulted in almost complete quenching of the BODIPY-FL fluorescence. As a result of this low background fluorescence, we obtained a 7-to 10-fold increase in fluorescence during calpain digestion of BODIPY-FL-casein compared with a 3-fold increase in fluorescence when using DTAF-labeled MAP2 (24) or a 4-to 5-fold increase in assays using a BODIPY-FL-casein labeled at 5 mol of BODIPY-FL/ mol casein (25) . Casein exists in a micellar form in aqueous solutions (31) . This micellar form may assist in bringing individual BODIPY-FL molecules in sufficiently close proximity to facilitate autoquenching, because even at 9 -11 BODIPY-FL molecules per casein molecule, only 1 out of 20 -24 amino acids in the casein molecule is labeled. It is unclear why the specific activities of -and m-calpain are identical when assayed using an autoquenching assay, whereas m-calpain has nearly a twofold higher specific activity than -calpain when assayed by using a FITC-casein assay (4, 36). The two proteases have identical or nearly identical subsite specificities (Thompson and Goll, unpublished results), so it is unlikely that they cleave different peptide bonds in the casein substrate.
Plotting fluorescence units vs calpain concentration indicates that fluorescence units of released BODIPY-FL increase linearly with increasing calpain concentration up to 800 ng of calpain/ml (160 ng of calpain in the assay) and depart only slightly from linearity up to 2500 ng of calpain/ml (500 ng of calpain in the assay; Fig. 3 ). Even at a calpain concentration of 100 ng/ml (20 ng of calpain in the assay), readings obtained after 30 min at 25°C were 120 -140 fluorescence units and were significantly above the readings of 70 -80 fluorescence units obtained for the blank samples (insert, Fig. 3 ). Hence, this assay can detect less than 10 ng of calpain activity and is nearly as sensitive as the most sensitive calpain assay reported thus far (24) . Linearity of the response can be extended to higher calpain concentrations by decreasing the assay time (cf. Fig. 2) .
Reproducibility of the microtiter plate assay. The microtiter plate assay is much faster than conventional assays of calpain activity, especially for large numbers of samples. Beginning with pipetting the reagents into the microtiter plate (i.e., excluding the time required to pipette the samples into the microtiter plates), a complete assay of 96 samples can be done in 15 min plus whatever incubation time was used (e.g., 30 min) compared with 90 min plus incubation time for the FITCcasein assay routinely used in our laboratory (4) . This difference increases as the number of samples being assayed increases. It is important to know, however, whether the microtiter plate assay is as precise/reproducible as the FITC-casein assay, whose reproducibility is comparable to or better than the reproducibility of other methods to assay calpain activity (4, 13, 16, 21, 24) . Therefore, we used both the FITC-casein procedure that we routinely use (4) and the microtiter plate assay described in this paper to assay those tubes that contained no calpain activity in the column chromatographic elutions obtained during purification of the calpains and compared the results from the two assays ( Table 1) . Because these tubes contained no calpain activity, the values obtained in assaying these tubes should be the same for all tubes assayed. Hence, this comparison is an estimate of the relative "baseline" stability of the two assays. This comparison indicates that the baseline stability of the two assay methods is similar, with the microtiter plate assay perhaps being even slightly better than the FITC-casein assay (Table  1) . Duplicate assays of tubes containing calpain activity are more repeatable (lower coefficients of variation) than assays of different tubes containing no activity, and the precision/repeatability of such duplicate assays is similar for the microtiter plate assay and the FITC-casein assay. The variation in duplicate assays of samples having calpain activity likely originates from a Calculations were done on tubes obtained from column chromatographic elutions during calpain purification; those tubes that contained no calpain activity in the elution profile were assayed. Blank assays indicated that the tube also contained no other proteolytic activity. The number of tubes that was assayed from each column is indicated. The tubes were first assayed by using the FITC-casein assay that has been used routinely in our laboratory (4) and then were assayed a second time by using the microtiter plate assay described in this article. Elution profiles from seven different (ion exchange, hydrophobic interaction, etc.) columns were used. The numbers are coefficients of variation, s x /x. different sources in the two assays; the FITC-casein assay requires multiple pipetting steps that introduce some variation, whereas the microtiter plate assay requires very few pipetting steps but has variation inherently associated with microtiter plate assays. The microtiter plate assay also is slightly more sensitive than the FITC-casein assay in addition to requiring much less time than the FITC-casein assay, and the laboratory has rapidly converted to the BODIPY-FL assay.
Kinetic studies. Several studies were done to determine the kinetic properties of the BODIPY-FL-labeled casein assay. Previous studies have shown that the K m values for the calpains range from 8.1 (15) to 53 (16) M for -calpain and from 10.0 (15) to 23.8 (14) M for m-calpain when using casein as a substrate and from 45 (18) to 49.6 (17) nM for -calpain when using fodrin as a substrate. Tompa et al. (24) reported that the K m for -calpain was 170 nM when DTAF-labeled MAP2 was used as a substrate. These differences in K m values have led to suggestions that "natural substrates" such as MAP2 or fodrin are better substrates than casein for the calpains because they have lower K m values than a casein substrate. Almost all casein-based assays, however, have used the increase in TCA-soluble peptides to estimate calpain activity (14, 15) , whereas the assays using "natural substrates" have used disappearance of the fodrin polypeptide in SDS-PAGE gels (17, 18) or an autoquenching assay (24) similar to that described in the present paper to measure calpain activity. Disappearance of a fodrin polypeptide requires only a single proteolytic cleavage, whereas generation of TCA-soluble peptides requires at least several and perhaps many proteolytic cleavages to produce peptides that are not precipitated by TCA. The Coomassie brilliant blue G-250 assay (16) also requires at least several cleavages before peptides that no longer react with Coomassie brilliant blue are produced. Comparison of the increase in fluorescence with the disappearance of the MAP2 polypeptide showed that the autoquenching assay also is sensitive to the first few proteolytic cleavages (24) . Hence, it is not clear whether the reported differences in K m values are due to differences between "natural" and casein substrates or whether these differences are due at least partly to the different methods used to measure proteolytic activity in these studies. Although there may be a concern that "internal filtering" can distort calculation of kinetic constants when fluorescence assays are used, there was no evidence of any internal filtering in our assays over the range of substrate concentrations that we used.
Estimates of K m values for -and m-calpain using BODIPY-FL-labeled casein as a substrate were 740 and 640 nM for and m-calpain, respectively (Fig. 4) . These K m values are only slightly larger than the 170 nM obtained when using MAP2 as a substrate and an autoquenching assay to estimate -calpain activity (24) . SDS-PAGE indicated that the increase in fluorescence in the BODIPY-FL-casein assay of calpain activity occurred already during the first several proteolytic cleavages of the casein molecule (Fig. 5 ), in agreement with the very rapid response that seems characteristic of autoquenching assays (23, 25, 32, 33) . It seems likely that one or two proteolytic cleavages are sufficient to alleviate some autoquenching, so autoquenching assays also are sensitive to the initial cleavages in proteolytic degradation of substrates in contrast to pro- duction of TCA-soluble peptides. Because K m values are the ratio of three rate constants, k Ϫ1 ϩ k 2 /k 1 , and because ability to measure the initial cleavages of a protein substrate may be expected to impact these apparent rate constants, it may be expected that the procedure used to measure rate of proteolysis would affect the K m values obtained. Thus, it is not clear that "natural substrates" have lower K m values or are "better" substrates than casein for assays of calpain activity. What is remarkable is that casein, which contains approximately 10 -15 Ca 2ϩ atoms per molecule, does not alter the Ca 2ϩ concentration required for activity of the calpains; removing all the Ca 2ϩ from casein by dialyzing against EDTA does not change the Ca 2ϩ concentration required for half-maximal proteolytic activity of the calpains (37) . Evidently, the Ca 2ϩ in casein is completely sequestered in micelles and is unavailable to the calpains (or to other proteolytic enzymes). This micellar nature of casein likely also influences its behavior in autoquenching assays of proteolytic activity.
Estimates of V max from the plots in Fig. 4 were 320 fluorescent units/min for -calpain and 354 fluorescent units/min for m-calpain, again indicating that the two proteases had similar specific activities in the BODIPY-FL assay. Because the specific activity of mcalpain is approximately twofold greater than the specific activity of -calpain when using the FITC-casein assay (4, 36) , and because the specific activities ofand m-calpain from different preparations varied somewhat when using the BODIPY-FL assay, it seemed possible that the BODIPY-FL assay was unusually sensitive to the oxidation state of the activesite Cys residue in the calpains. Therefore, we incubated the calpains for 1 h in the presence of different concentrations of TCEP to learn whether such incubation would affect the specific activity of the calpains. TCEP is a more potent and stable sulfhydryl reducing agent than dithiothreitol and is much more effective than the MCE that we normally use in our calpain assays (38) . Incubation and assay of the calpains in 10 mM TCEP had no effect on the specific activity of either -or m-calpain when compared to incubation and assay in 14.1 mM MCE (Fig. 6) . Indeed, incubation and assay of -and m-calpain at higher TCEP concentrations up to 50 mM actually seemed to inhibit their activity slightly (Fig. 6) . Consequently, it seems unlikely that the state of the SH group in the active site of the calpains is involved in the unusual behavior of the calpains in the BODIPY-FL assay.
SUMMARY
The BODIPY-FL-casein assay has a number of advantages over previous methods described to assay activity of the calpains (and other proteolytic enzymes): (1) Because the procedure does not require precipitation and removal of undegraded protein, it is much faster than many of the procedures that have been described, and it can easily be used for continuous monitoring of casein degradation. (2) It is easily adapted to a microtiter plate format, so it can be used to screen large numbers of samples without modification. (3) Casein is an inexpensive and readily available protein substrate that more closely mimics the natural substrates of proteolytic enzymes, especially endoproteinases, than synthetic peptide substrates do; casein is cleaved by the calpains, in contrast to other potential protein substrates such as BSA; it has K m values for the calpains that are similar to those of other substrates such as MAP2 and fodrin that may be natural substrates for the calpains; and there is no reason to   FIG. 6 . Effect of incubation for 1 h and assay in different concentrations of TCEP on the activity of -and m-calpain. Conditions: different concentrations of -or m-calpain from 0.5 to 2.5 g/ml were incubated for 1 h at 25°C in 20 mM Tris-HCl, pH 7.5; 100 mM KCl; 1 mM EDTA and the MCE or TCEP concentrations shown followed by assay of proteolytic activity at 2.5 g of BODIPY-FL casein/ml in 20 mM Tris-HCl, pH 7.5; 100 mM KCl; 1 mM EDTA; 5 mM Ca 2ϩ for 30 min at 25°C.
believe that calpain hydrolysis of casein is inherently different from calpain hydrolysis of MAP2 or fodrin, which are not readily available in quantity. (4) The BODIPY-FL assay detects 10 ng (4.5 nM) of calpain and is nearly as sensitive as the most sensitive calpain assay reported thus far (24) , which produced a 1.6-fold increase in fluorescence with 5 ng of calpain in a spectrofluorometer. (5) The autoquenching approach is responsive to the first few cleavages of a protein substrate; it does not require a large number of cleavages to produce peptide fragments that are small enough to be soluble in TCA and is a useful approach to assay proteolytic enzymes having a very restricted specificity such as the calpains. The microtiter plate assay requires a fluorescent microplate reader, but these instruments are rapidly becoming more widely available in laboratories.
The BODIPY-FL fluorophore also has a number of characteristics that make it superior to other fluorophores such as fluorescein; these are summarized in the Molecular Probes Handbook of Fluorescent Probes and Research Chemicals (Molecular Probes, Inc., Eugene, OR) and include a high extinction coefficient and high fluorescent quantum yield. Moreover, because the BODIPY-FL molecule contains no ionic groups, its spectra are insensitive to solvent polarity and pH. We have used the BODIPY-FL-labeled casein assay described in the preceding paragraphs to measure activity of other proteases such as trypsin and chymotrypsin and have found that it is also an excellent substrate for measuring the activity of these proteolytic enzymes. As described earlier (25) , the assay should be useful for any protease that cleaves casein. Although several papers have suggested that the BODIPY-FL assay is 20-to 100-fold more sensitive than the FITC-casein assay for proteolytic activity (4), we find that the BODIPY-FL-labeled casein assay is approximately 5-to 10-fold more sensitive than the FITC-casein assay when compared directly in our laboratory using the calpains as proteases. Finally, the BODIPY-FL assay cannot be used to measure the number of peptide bonds cleaved in a proteolytic degradation such as pH stat or direct assays of amino groups can (5) (6) (7) (8) .
